Tag Archives: risk

Study: lack of sleep in childhood increases obesity risk – Xinhua

&h=100&w=100&zc=1&q=90" alt="Study: lack of sleep in childhood increases obesity risk – Xinhua" class="alignleft" />

SAMAA TV Study: lack of sleep in childhood increases obesity risk Xinhua BEIJING, Sept. 7 (Xinhuanet) — Infants and young children who don't sleep enough at night have a higher risk of obesity later on in life, said a study published in the September issue Archives of Pediatrics & Adolescent Medicine.

Full Story

Osteoporosis drugs linked to cancer – Celebrities With Diseases

&h=100&w=100&zc=1&q=90" alt="Osteoporosis drugs linked to cancer – Celebrities With Diseases" class="alignleft" />

Sydney Morning Herald Osteoporosis drugs linked to cancer Celebrities With Diseases Long-term users of bone strengthening medications called oral bisphosphonates have nearly double the risk of developing esophageal cancer, a study from Oxford University claims. The study involved some 80000 patients and took place over the course of … Osteoporosis Drugs Tied to Esophageal Cancer ABC News Osteoporosis Drugs May Be Linked to Cancer Risk WebMD Osteoporosis drugs linked to esophageal cancer Food Consumer U.S.

Full Story

Hormone in Hair May Reveal Heart Risk

&h=100&w=100&zc=1&q=90" alt="Hormone in Hair May Reveal Heart Risk" class="alignleft" />

High levels of cortisol in the hair shaft may increase the risk of heart attack, a study shows.

Full Story

Bone-building drugs double the risk of esophageal cancer, but the risk is … – Los Angeles Times

&h=100&w=100&zc=1&q=90" alt="Bone-building drugs double the risk of esophageal cancer, but the risk is … – Los Angeles Times" class="alignleft" />

Telegraph.co.uk Bone-building drugs double the risk of esophageal cancer, but the risk is … Los Angeles Times The family of bone-building drugs that includes Fosamax, Actonel and Boniva can double the risk of developing throat cancer, researchers reported Thursday in the latest development in what has become a confusing discussion. Other studies have reported …

Full Story

BMJ links bone drugs with esophageal cancer – FiercePharma

&h=100&w=100&zc=1&q=90" alt="BMJ links bone drugs with esophageal cancer – FiercePharma" class="alignleft" />

CBC.ca BMJ links bone drugs with esophageal cancer FiercePharma Popular drugs for osteoporosis have raised another safety flag. This time, it's the risk of esophageal cancer that new data links to bisphosphonates, a class of drugs that includes such blockbusters as Merck's Fosamax, Roche's Boniva and Novartis' ..

Full Story

Osteoporosis Drugs May Be Linked to Cancer Risk – WebMD

&h=100&w=100&zc=1&q=90" alt="Osteoporosis Drugs May Be Linked to Cancer Risk – WebMD" class="alignleft" />

Daily Mail Osteoporosis Drugs May Be Linked to Cancer Risk WebMD Sept.

Full Story

Osteoporosis Drugs May Be Linked to Cancer Risk

&h=100&w=100&zc=1&q=90" alt="Osteoporosis Drugs May Be Linked to Cancer Risk" class="alignleft" />

The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.

Full Story

Weight Loss Pill Meridia Ups Heart Attack, Stroke

&h=100&w=100&zc=1&q=90" alt="Weight Loss Pill Meridia Ups Heart Attack, Stroke" class="alignleft" />

People who take Abbott’s weight-loss pill Meridia have a higher risk of non-fatal heart attack and stroke, a study sponsored by the drug’s maker finds.

Full Story

KYOTO and JIKEI HEART analyses show benefit of valsartan in Japanese hypertensive patients

Adding valsartan to therapy in high-risk hypertensive patients reduced the risk of cardiovascular events more than conventional non-ARB treatment in both the primary- and secondary-prevention… For complete story visit theheart.org.

Full Story

Low Vitamin D Linked to Heart Failure Deaths

&h=100&w=100&zc=1&q=90" alt="Low Vitamin D Linked to Heart Failure Deaths" class="alignleft" />

Low vitamin D levels are associated with a higher risk of death and hospitalization in people with heart failure, researchers report.

Full Story
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